Arno Friedl
10Patents
7h-index
40Co-inventors
58Inventor score
Filing activity: Jun 13, 1996 → Jun 25, 2003
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6573278B2 | Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases | Chemistry; Metallurgy | 43 | Expired |
| US6284788A | Use of known agonists of the central cannabinoid receptor CB1 | Human Necessities | 34 | Expired |
| US6262112A | Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases | Chemistry; Metallurgy | 30 | Expired |
| US6469054B1 | Aryl sulphonamides and analogues | Chemistry; Metallurgy | 15 | Expired |
| US6545050B1 | Aryl sulphonamide amino acid esters and analogues | Emerging Cross-Sectional Technologies | 13 | Expired |
| US7202243B2 | Substituted imidazotriazines | Human Necessities | 12 | Expired |
| US6936609B2 | Imidazotriazines for use as phosphodiesterase inhibitors | Human Necessities | 10 | Expired |
| US6525087B2 | Use of known agonists of the central cannabinoid receptor CB1 | Human Necessities | 3 | Expired |
| US5942529A | Benzisothiazolyl-substituted aminomethylchromans | Chemistry; Metallurgy | 3 | Expired |
| US6727279B2 | Arylsulphonamides and analogues | Chemistry; Metallurgy | 1 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.